First Horizon Corporation’s Biogen BIIB Stock Holding History

First Horizon Corporation’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94.6K	Buy	438 +257	+142%	+$49.2K	﹤0.01%	545
2026 Q1	$33.2K	Buy	181 +12	+7%	+$2.21K	﹤0.01%	747
2025 Q4	$29.7K	Buy	+169	New	+$27.6K	﹤0.01%	834
2021 Q2	$41K	Buy	119 +19	+19%	+$5.76K	﹤0.01%	410
2021 Q1	$27K	Buy	100 +21	+27%	+$5.66K	﹤0.01%	487
2020 Q4	$19K	Sell	79 -15	-16%	-$3.87K	﹤0.01%	521
2020 Q3	$26K	Buy	+94	New	+$26.2K	﹤0.01%	439

Other funds holding BIIB

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

First Horizon Corporation's BIIB Position: Q2 2026 in Review

First Horizon Corporation increased its Biogen (BIIB) stake by 142% in Q2 2026, buying an estimated $49.2K and bringing the position to 438 shares worth $94.6K. The position accounts for ﹤0.01% of the portfolio, ranked #545.

First Horizon Corporation first reported a position in BIIB in Q3 2020 and has held it in 7 quarters since. 430 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

First Horizon Corporation held 438 shares of Biogen worth $94.6K as of Q2 2026.
First Horizon Corporation bought 257 Biogen shares in Q2 2026, an estimated $49.2K.
Biogen made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #545 holding.
First Horizon Corporation first reported a position in Biogen in Q3 2020 and has held it in 7 quarters since.
430 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.